Loading...
XSHE
300391
Market cap103mUSD
Dec 05, Last price  
2.08CNY
1D
-7.14%
1Q
-48.51%
Jan 2017
-85.70%
IPO
-49.97%
Name

Changjiang Pharmaceutical Group Co Ltd

Chart & Performance

D1W1MN
XSHE:300391 chart
P/E
P/S
6.53
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
-31.22%
Revenues
112m
-90.68%
128,131,531177,609,816223,180,306225,272,826255,385,121243,428,659191,250,584234,866,048744,154,806881,022,368725,310,8821,214,503,9602,361,946,4501,615,322,9341,197,562,401111,625,000
Net income
-628m
L+3.68%
17,770,45430,808,33237,133,20735,477,99134,958,54328,718,7065,027,9974,221,13969,716,990101,988,481025,319,98849,104,5240-605,653,315-627,962,000
CFO
-75m
L-48.92%
21,348,50027,067,80030,360,68629,341,43821,658,761040,984,292038,957,030137,087,58122,302,17832,805,640230,987,8900-147,425,871-75,304,000
Dividend
May 10, 20190.05 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Changjiang Pharmaceutical Group Co., Ltd., together with its subsidiaries, designs, researches, develops, produces, and sells turbochargers in China. It offers turbocharger housing, engine exhaust manifolds, and valve body auto parts, as well as engines. The company also produces and sells solar cell module equipment and photovoltaic modules, as well as engages in the solar energy, lithium batteries, energy storage, and other energy industry businesses. Its products are used in automobiles, construction machinery, agricultural machinery, ship power, generator sets, and other industries. Kangyue Technology Co., Ltd. also exports its products to Americas, Europe, East Asia, and internationally. The company was formerly known as Kangyue Technology Co., Ltd. and changed its name to Changjiang Pharmaceutical Group Co., Ltd. in March 2023. Changjiang Pharmaceutical Group Co., Ltd. was founded in 1963 and is based in Shouguang, China.
IPO date
Aug 01, 2014
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT